Angstwurm, Klemens, Amelie Vidal, Henning Stetefeld, Christian Dohmen, Philipp Mergenthaler, Siegfried Kohler, Silvia Schönenberger, Julian Bösel, Ursula Neumann, De-Hyung Lee, Stefan T. Gerner, Hagen B. Huttner, Andrea Thieme, , Juliane Dunkel, Christian Roth, Hauke Schneider, Eik Schimmel, Heinz Reichmann, Hannah Fuhrer, Benjamin Berger, Ingo Kleiter, Christiane Schneider-Gold, Anke Alberty, Jan Zinke, Berthold Schalke, Andreas Steinbrecher, Andreas Meisel, Bernhard Neumann.

Early Tracheostomy Is Associated With Shorter Ventilation Time and Duration of ICU Stay in Patients With Myasthenic Crisis—A Multicenter Analysis

Journal of Intensive Care Medicine, January 2022; 37(1):32-40, DOI: 10.1177/0885066620967646  

Beck, J.; Jaekel, A.K.; Zeller, F.L.; Kowollik, M.; Kurze, I.; Kaufmann, A.; Feneberg, W.; Brandt, A.; Flachenecker, P.; Henze, T.; et al.

Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple Sclerosis.

Diagnostics 2022; 12:191, DOI: 10.3390/diagnostics12010191  

Ringelstein, Marius, Ilya Ayzenberg, Gero Lindenblatt, Katinka Fischer, Anna Gahlen, Giovanni Novi, Helen Hayward-Könnecke, Sven Schippling, Paulus S. Rommer, Barbara Kornek, Tobias Zrzavy, Damien Biotti, Jonathan Ciron, Bertrand Audoin, Achim Berthele, Katrin Giglhuber, Helene Zephir, Tania Kümpfel, Robert Berger, Joachim Röther, Vivien Häußler, Jan-Patrick Stellmann, Daniel Whittam, Anu Jacob, Markus Kraemer, Antoine Gueguen, Romain Deschamps, Antonios Bayas, Martin W. Hümmert, Corinna Trebst, Axel Haarmann, Sven Jarius, Brigitte Wildemann, Matthias Grothe, Nadja Siebert, Klemens Ruprecht, Friedemann Paul, Nicolas Collongues, Romain Marignier, Michael Levy, Michael Karenfort, Michael Deppe, Philipp Albrecht, Kerstin Hellwig, Ralf Gold, Hans-Peter Hartung, Sven G. Meuth, Ingo Kleiter, Orhan Aktas, on behalf of the Neuromyelitis Optica Study Group (NEMOS).

Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders.

Neurology: Neuroimmunology & Neuroinflammation January 2022; 9(1): e1100

DOI: 10.1212/NXI.0000000000001100  

Asseyer, S., Henke, E., Trebst, C., Hümmert, M.W., Wildemann, B., Jarius, S., Ringelstein, M., Aktas, O., Pawlitzki, M., Korsen, M., Klotz, L., Siebert, N., Ruprecht, K., Bellmann‐Strobl, J., Wernecke, K.‐D., Häußler, V., Havla, J., Gahlen, A., Gold, R., Paul, F., Kleiter, I., Ayzenberg, I. and Neuromyelitis Optica Study Group.

Pain, depression, and quality of life in adults with MOG‐antibody–associated disease.  

European Journal of Neurology 2021; 28:1645-1658, DOI: 10.1111/ene.14729

Ayzenberg, Ilya, Daniel Richter, Eugenia Henke, Susanna Asseyer, Friedemann Paul, Corinna Trebst, Martin W. Hümmert, Joachim Havla, Tania Kümpfel, Marius Ringelstein, Orhan Aktas, Brigitte Wildemann, Sven Jarius, Vivien Häußler, Jan-Patrick Stellmann, Makbule Senel, Luisa Klotz, Hannah L. Pellkofer, Martin S. Weber, Marc Pawlitzki, Paulus S. Rommer, Achim Berthele, Klaus-Dieter Wernecke, Kerstin Hellwig, Ralf Gold, Ingo Kleiter, on behalf of the NEMOS (Neuromyelitis Optica Study Group).

Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody–Seropositive Patients.

Neurology: Neuroimmunology & Neuroinflammation May 2021, 8(3):e985

DOI:10.1212/NXI.0000000000000985

Ayzenberg, I., Kleiter, I.  

Therapie antikörpervermittelter Enzephalomyelitiden.  

Der Nervenarzt 2021; 92, 334–348, DOI: 10.1007/s00115-021-01090-4

Domurath Burkhard, Peter Flachenecker, Thomas Henze, Wolfgang Feneberg, Anna Brandt, Ines Kurze, Ruth Kirschner-Hermanns, Albert Kaufmann, Jörn Bremer, Manuela Vonthien, Kerstin Ratering, Christoph Schäfer, Will Nelson Vance & Paul Schmidt.

Aktuelles zu neurogenen Dysfunktionen des unteren Harntraktes bei Multipler Sklerose.  

Der Nervenarzt 2021; 92:349-358, DOI: 10.1007/s00115-020-01046-0

Barabasch Anna, Karin Riemann-Lorenz, Christopher Kofahl, Jutta Scheiderbauer, Desiree Eklund, Ingo Kleiter, Jürgen Kasper, Sascha Köpke, Susanne Lezius, Antonia Zapf, Anne Christin Rahn & Christoph Heesen.

Impact of a multimedia website with patient experiences of multiple sclerosis (PExMS) on immunotherapy decision-making: study protocol for a pilot randomised controlled trial in a mixed-methods design.  

Pilot Feasibility Stud 7, 16 (2021), DOI: 10.1186/s40814-020-00749-0

Fujihara, K., Hattori, S., Kleiter, I., Levy, M., Matsuda, Y., Mitsutake, A., Haramura, M., Palace, J., Yamamura, T. on behalf of The Guthy-Jackson Charitable Foundation NMOSD Quality of Life Working Group (2021).

Patient-reported burden of symptoms in neuromyelitis optica: A secondary analysis on pain and quality of life.  

Journal of the Neurological Sciences 2021 Sep 15; 428:117546, DOI: 10.1016/j.jns.2021.117546

Giovannelli Jonathan,Jonathan Ciron,Mikael Cohen,Ho-Jin Kim,Su-Hyun Kim,Jan-Patrik Stellmann,Ingo Kleiter,Morgan McCreary,Benjamin M. Greenberg,Romain Deschamps,Bertrand Audoin,Elisabeth Maillart,Caroline Papeix,Nicolas Collongues,Bertrand Bourre,David Laplaud,Xavier Ayrignac,Françoise Durand-Dubief,Aurélie Ruet,Sandra Vukusic,Romain Marignier,Luc Dauchet,Hélène Zephir,NEMOS (Neuromyelitis Optica Study Group in Germany), NOMADMUS (Neuromyelitis Optica study Group in France), OFSEP (Observatoire Français de la Sclérose en Plaques) investigators.

A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica.

Annals of Clinical and Translational Neurology 2021 October; 8(10):2025-2037

DOI: 10.1002/acn3.51451  

Havla, Joachim, Thivya Pakeerathan, Carolin Schwake, Jeffrey L. Bennett, Ingo Kleiter, Ana Felipe-Rucián, Stephanie C. Joachim, Amelie S. Lotz-Havla, Tania Kümpfel, Markus Krumbholz, Eva M. Wendel, Markus Reindl, Charlotte Thiels, Thomas Lücke, Kerstin Hellwig, Ralf Gold, Kevin Rostasy & Ilya Ayzenberg.

Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?

Journal of Neuroinflammation 2021; 18:121, DOI: 10.1186/s12974-021-02160-9  

König Nicole, Henning R. Stetefeld, Christian Dohmen, Philipp Mergenthaler, Siegfried Kohler, Silvia Schönenberger, Julian Bösel, De-Hyung Lee, Stefan T. Gerner, Hagen B. Huttner, Hauke Schneider, Heinz Reichmann, Hannah Fuhrer, Benjamin Berger, Jan Zinke, Anke Alberty, Ingo Kleiter, Christiane Schneider-Gold, Christian Roth, Juliane Dunkel, Andreas Steinbrecher, Andrea Thieme, Felix Schlachetzki, Ralf A. Linker, Klemens Angstwurm, Andreas Meisel & Bernhard Neumann for The German Myasthenic Crisis Study Group.

MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation.  

Journal of Neurology 2021; 268:4824–4833, DOI: 10.1007/s00415-021-10603-9

Lehner, Katharina, Wolfram Ziegler, & for the KommPaS Study Group*.

Clinical measures of communication limitations in dysarthria assessed through crowdsourcing: specificity, sensitivity, and retest-reliability.

Clinical Linguistics & Phonetics 2021, 1-22, published online 12 Nov 2021

DOI: 10.1080/02699206.2021.1979658

* Members Ingo Kleiter, Ursula Sühn (Marianne-Strauß-Klinik Berg)

Mokry, C., Warnke, C., Gehring, K., H. Hegen, A. Salmen, M. Krämer, I. Kleiter, E. Fasshauer, J. Scheiderbauer, A. Berthele & C. Heesen.

Implementierungsstudie zur neuen Multiple Sklerose Leitlinie.

DGNeurologie 2021; 4: 241-235, DOI: 10.1007/s42451-021-00344-4  

Mokry C, Warnke C, Gehring K, Hegen H, Salmen A, Kramer M, Kleiter I, Fasshauer E,

Scheiderbauer J, Luhmann D, Kopke S, Berthele A, Heesen C. Implementation study of the

2021 German guideline for diagnosis and treatment of multiple sclerosis.

Multiple Sclerosis and Related Disorders 2021 Dec 3; 57:103434, DOI: 10.1016/j.msard.2021.103434.  

Pache F, Ringelstein M, Aktas O, Kleiter I, Jarius S, Siebert N, Bellmann-Strobl J, Paul F,

Ruprecht K.

C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.

Journal of Neuroimmunology 2021, 360: 577699, DOI: doi.org/10.1016/j.jneuroim.2021.577699  

Sippel, A., Scheiderbauer, J., Eklund, D., Arnade, S., Schmidt, S., Kleiter, I., Morrison, R., Kofahl, C., Heesen, C.

Development and Evaluation of a Website With Patients Experiences of Multiple Sclerosis: A Mixed Methods Study.

BMC Neurology, 2021, preprint, DOI: 10.21203/rs.3.rs-846116/v1  

Sippel Anna, Karin Riemann-Lorenz, Jutta Scheiderbauer, Ingo Kleiter, Rebecca Morrison, Christopher Kofahl & Christoph Heesen.

Patients experiences with multiple sclerosis disease-modifying therapies in daily life – a qualitative interview study.

BMC Health Services Research 2021; 21:1141, DOI: 10.1186/s12913-021-07012-z

Ziegler, W., Lehner, K., & KommPaS Study Group*.

Crowdsourcing as a tool in the clinical assessment of intelligibility in dysarthria: How to deal with excessive variation.  

Journal of Communication Disorders 2021 Sep-Oct; 93:106135, DOI: 10.1016/j.jcomdis.2021.106135

Members Ingo Kleiter, Ursula Sühn (Marianne-Strauß-Klinik Berg)

Abdelhak, Ahmed, Andre Huss, Alexander Stahmann, Makbule Senel, Markus Krumbholz, Markus C. Kowarik, Joachim Havla, Tania Kümpfel, Ingo Kleiter, Isabella Wüstinger, Uwe K. Zettl, Margit Schwartz, Romy Roesler, Tim Friede, Albert C. Ludolph, Ulf Ziemann, Hayrettin Tumani.  

Explorative Study of Emerging Blood Biomarkers in Progressive Multiple Sclerosis (EmBioProMS): Design of a Prospective Observational Multicentre Pilot Study.

Contemporary Clinical Trials Communications 18 (June 1, 2020): 100574.

DOI: 10.1016/j.conctc.2020.100574.

Aly, Lilian, Joachim Havla, Gildas Lepennetier, Till F.M. Andlauer, Christopher Sie, Eva-Maria Strauß, Muna-Miriam Hoshi, et al.

Inner Retinal Layer Thinning in Radiologically Isolated Syndrome Predicts Conversion to Multiple Sclerosis.

European Journal of Neurology November 2020; 27(11):2217-2224, DOI: 10.1111/ene.14416

Domurath B, Kurze I, Kirschner-Hermanns R, Kaufmann A, Feneberg W, Schmidt P, Henze T, Flachenecker P, Brandt A, Vance WN, Beck J, Vonthien M, Ratering K, the MS Consensus Group.

Neurourological assessment in people with multiple sclerosis (MS): a new evaluated algorithm.

Multiple Sclerosis and Related Disorders 2020; 44:102248, DOI: 10.1016/j.msard.2020.102248

Faissner, Simon, Florian Graz, Sabrina Reinehr, Laura Petrikowski, Steffen Haupeltshofer, Ulas Ceylan, Gesa Stute, Stephan Winklmeier, Florence Pache, Friedemann Paul, Klemens Ruprecht, EdgarMeinl, H. Burkhard Dick, Ralf Gold, Ingo Kleiter, Stephanie C. Joachim.

Binding Patterns and Functional Properties of Human Antibodies to AQP4 and MOG on Murine Optic Nerve and Retina.

Journal of Neuroimmunology 2020 Feb 20; 342: 577194, DOI: 10.1016/j.jneuroim.2020.577194.

Feneberg W, Kleiter I.

Die multimodale Therapie der progredienten multiplen Sklerose.  

Neuro aktuell 2020; 8:33-37

Feneberg W, Kleiter I.

Multimodale Therapie der fortgeschrittenen Multiplen Sklerose.  

NeuroTransmitter 2020; 31 (1-2): 27-30

Fujihara, Kazuo, Jeffrey L. Bennett, Jerome de Seze, Masayuki Haramura, Ingo Kleiter, Brian G. Weinshenker, Delene Kang, Tabasum Mughal, and Takashi Yamamura.  

Interleukin-6 in Neuromyelitis Optica Spectrum Disorder Pathophysiology.

Neurology - Neuroimmunology Neuroinflammation 2020 Sep 3; 7(5):e841

DOI: 10.1212/NXI.0000000000000841

Jarius S, Pellkofer H, Siebert N, Korporal-Kuhnke M, Hummert MW, Ringelstein M, Rommer

PS, Ayzenberg I, Ruprecht K, Klotz L, Asgari N, Zrzavy T, Hoftberger R, Tobia R, Buttmann

M, Fechner K, Schanda K, Weber M, Asseyer S, Haas J, Lechner C, Kleiter I, Aktas O,

Trebst C, Rostasy K, Reindl M, Kumpfel T, Paul F, Wildemann B; in cooperation with the

Neuromyelitis Optica Study Group (NEMOS).  

Cerebrospinal fluid findings in patients with

myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar

punctures in 100 adult patients.

Journal of Neuroinflammation 2020 Sep 3;17(1):261, DOI: 10.1186/s12974-020-01824-2

Jarius, Sven, Christian Lechner, Eva M. Wendel, Matthias Baumann, Markus Breu, Mareike Schimmel, Michael Karenfort, Adela Della Marina, Andreas Merkenschlager, Charlotte Thiels, Astrid Blaschek, Michela Salandin, Steffen Leiz, Frank Leypoldt, Alexander Pschibul, Annette Hackenberg, Andreas Hahn, Steffen Syrbe, Jurgis Strautmanis, Martin Häusler, Peter Krieg, Astrid Eisenkölbl, Johannes Stoffels, Matthias Eckenweiler, Ilya Ayzenberg, Jürgen Haas, Romana Höftberger, Ingo Kleiter, Mirjam Korporal-Kuhnke, Marius Ringelstein, Klemens Ruprecht, Nadja Siebert, Kathrin Schanda, Orhan Aktas, Friedemann Paul, Markus Reindl, Brigitte Wildemann, and Kevin Rostásy, in cooperation with the BIOMARKER study group and the Neuromyelitis optica Study Group (NEMOS).

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.

Journal of Neuroinflammation 2020; 17:262, DOI: 10.1186/s12974-020-01825-1

Kleiter Ingo, und Renate Hofreiter.  

Multiple Sklerose Aufhalten.

Heilberufe 2020 March 1; 72(3):12–14, DOI: 10.1007/s00058-020-1437-6.

Kleiter Ingo, Ilya Ayzenberg, Joachim Havla, Carsten Lukas, Iris-Katharina Penner, Christine Stadelmann, and Ralf A Linker.

The Transitional Phase of Multiple Sclerosis: Characterization and Conceptual Framework.

Multiple Sclerosis and Related Disorders 2020 Sep 01; 44:102242, DOI: 10.1016/j.msard.2020.102242  

Limmroth, Volker, Tjalf Ziemssen, Ingo Kleiter, Bert Wagner, Stephan Schmidt, Christoph Lassek, Monika Baier-Ebert, Guillaume Wendt, Ralf Dechend, and Wilhelm Haverkamp.

A Comprehensive Monitoring Study on Electrocardiographic Assessments and Cardiac Events after Fingolimod First Dose-Possible Predictors of Cardiac Outcomes.

Frontiers in Neurology 2020; 11: 818, DOI: 10.3389/fneur.2020.00818

Ringelstein Marius, Jens Harmel, Hanna Zimmermann, Alexander U. Brandt, Friedemann Paul, Axel Haarmann, Mathias Buttmann, Martin W. Hümmert, Corinna Trebst, Christoph Schroeder, Ilya Ayzenberg, Ingo Kleiter, Kerstin Hellwig, Joachim Havla, Tania Kümpfel, Sven Jarius, Brigitte Wildemann, Paulus Rommer, Martin S. Weber, Hannah Pellkofer, Luise Röpke, Christian Geis, Nele Retzlaff, Uwe Zettl, Michael Deppe, Luisa Klotz, Kim Young, Jan-Patrick Stellmann, Matthias Kaste, Pawel Kermer, Wael Marouf, Florian Lauda, Hayrettin Tumani, Jonas Graf, Alexander Klistorner, Hans-Peter Hartung, Orhan Aktas, Philipp Albrecht, on behalf of the Neuromyelitis Optica Study Group (NEMOS).

Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.

Neurology 2020 January 28;94(4):e407-e418, DOI: 10.1212/WNL.0000000000008684  

Solari A., A. Giordano, J. Sastre-Garriga, S. Köpke,e, A. C. Rahn, I. Kleiter, K. Aleksovska, M. A. Battaglia, J. Bay, . Copetti, J. Drulovic, L. Kooij, J. Mens, E. R. Meza Murillo, I. Milanov, R. Milo, T. Pekmezovic, J. Vosburgh, E. Silber, S. Veronese, F. Patti, R. Voltz, D. Oliver and on behalf of the guideline task force.

EAN guideline on palliative care of people with severe, progressive multiple sclerosis.

European Journal of Neurology 2020 Aug; 27(8):1510-1529, DOI:  https://doi.org/10.1111/ene.14248

Journal of Palliative Medicine 2020 Oct.; 23(11):1426–1443, DOI: 10.1089/jpm.2020.0220  

This article is co‐published by the European Journal of Neurology and the Journal of Palliative Medicine.

Whittam D. H., V. Karthikeayan, E. Gibbons, R. Kneen, S. Chandratre, O. Ciccarelli, Y. Hacohen, J. de Seze, K. Deiva, R. Q. Hintzen, B. Wildemann, S. Jarius, I. Kleiter, K. Rostasy, P. Huppke, B. Hemmer, F. Paul, O. Aktas, A. K. Pröbstel, G. Arrambide, M. Tintore, M. P. Amato, M. Nosadini, M. M. Mancardi, M. Capobianco, Z. Illes, A. Siva, A. Altintas, G. Akman-Demir, L. Pandit, M. Apiwattankul, J. Y. Hor, S. Viswanathan, W. Qiu, H. J. Kim, I. Nakashima, K. Fujihara, S. Ramanathan, R. C. Dale, M. Boggild, S. Broadley, M. A. Lana-Peixoto, D. K. Sato, S. Tenembaum, P. Cabre, D. M. Wingerchuk, B. G. Weinshenker, B. Greenberg, M. Matiello, E. C. Klawiter, J. L. Bennett, A. I. Wallach, I. Kister, B. L. Banwell, A. Traboulsee, D. Pohl, J. Palace, M. I. Leite, M. Levy, R. Marignier, T. Solomon, M. Lim, S. Huda & A. Jacob.  

Treatment of MOG Antibody Associated Disorders: Results of an International Survey.  

Journal of Neurology 2020; 267:3565-3577, DOI: 10.1007/s00415-020-10026-y

BEITRÄGE IN BÜCHERN

Multiple Sklerose: verstehen, Symptome behandeln, mit der Krankheit leben / Thomas Henze (Hrsg.).  

Co-Autoren u.a. Birgit Basedow-Rajwich, Wolfgang Feneberg, Ingo Kleiter, Walter Pöllmann, Michaela Starck. - 4. Aufl. - München: Zuckschwerdt, 2020.

Basedow-Rajwich, Birgit, and Ingo Kleiter.  

Reader Response: Inpatients with Neurologic Disease Referred for Palliative Care Consultation. [Reponse to: Taylor BL, O’Riordan DL, Pantila SZ, Creutzfeldt CJ. Inpatients with neurologic disease referred for palliative care consultation.  

Neurology 2019; 92:e1975–e1981.]

Haupeltshofer Steffen, Teresa Leichsenring, Sarah Berg, Xiomara Pedreiturria, Stephanie C. Joachim, Iris Tischoff, Jan-Michel Otte, Tobias Bopp, Massimo C. Fantini, Charlotte Esser, Dieter Willbold, Ralf Gold, Simon Faissner, and  Ingo Kleiter.  

Smad7 in Intestinal CD4+ T Cells Determines Autoimmunity in a Spontaneous Model of Multiple Sclerosis.  

Proceedings of the National Academy of Sciences 2019 Dec 17; 116 (51): 25860

DOI: 10.1073/pnas.1905955116  

Köhler, W., C. G. Bien, S. Ehrlich, J. Faiss, C. Finke, R. Gold, A. Günther, L. Harms, F. Heigl, J. Heine, F. Hoffmann, R. W. C. Janzen, G. J. Jungehülsing, B. Kieseier, I. Kleiter, A. Kraft, F. Paul, H. Prüß, S. Schimrigk, C. Sommer, M. Stettner, C. Trebst, H. Tumani.  

Konsensuspapier zum Einsatz der Therapeutischen Apherese in der Neurologie.  

DGNeurologie 2019 Jan; 2(1):15–33, DOI: 10.1007/s42451-018-0051-1

Köpke, S., Giordano, A., Veronese, S., Rahn, A. C., Kleiter, I., Basedow-Rajwich, B., … Solari, A.  Patient and caregiver involvement in formulation of guideline questions: Findings from the EAN Guideline on Palliative Care of People with Severe Multiple Sclerosis.  

European Journal of Neurology 2019; 26(1):41-50, DOI: 10.1111/ene.13760  

Li, Xuan, Christian Clappier, Ingo Kleiter, and Rainer Heuchel.  

Tamoxifen Affects Chronic Pancreatitis-Related Fibrogenesis in an Experimental Mouse Model: An Effect beyond Cre Recombination.  

FEBS Open Bio 2019 Oct 1; 9 (10): 1756–68, DOI: https://doi.org/10.1002/2211-5463.12714

Metzdorf, Judith, Zaynab Hobloss, Sibylle Schlevogt, Ilya Ayzenberg, Sarah Stahlke, Xiomara Pedreiturria, Steffen Haupeltshofer, Ralf Gold, Lars Tönges, and Ingo Kleiter.  

Fingolimod for Irradiation-Induced Neurodegeneration.  

Frontiers in Neuroscience 2019; 13: 699, DOI: 10.3389/fnins.2019.00699  

Solari, Alessandra, Ambra Mara Giovannetti, Andrea Giordano, Carla Tortorella, Valentina Torri Clerici, Giampaolo Brichetto, Franco Granella, … Ingo Kleiter, et al.  

Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results from an Online Survey in Italy and Germany.  

Frontiers in Neurology 2019; 10: 916, DOI : 10.3389/fneur.2019.00916

Tuncer, Eylul, Raquel R. Calçada, Daniel Zingg, Sandra Varum, Phil Cheng, Sandra N. Freiberger, Chu-Xia Deng, Ingo Kleiter, Mitchell P. Levesque, Reinhard Dummer, and Lukas Sommer.  

SMAD Signaling Promotes Melanoma Metastasis Independently of Phenotype Switching.  

The Journal of Clinical Investigation 2019; 129(7):2702-2716, DOI: 10.1172/JCI94295  

Yamamura, Takashi, Ingo Kleiter, Kazuo Fujihara, Jacqueline Palace, Benjamin Greenberg, Beata Zakrzewska-Pniewska, Francesco Patti, et al.  

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder.

The New England Journal of Medicine 2019 Nov 27; 381(22): 2114–24

DOI: 10.1056/NEJMoa1901747  

Basedow-Rajwich, B., Montag, T., Duckert, A., Schulz, C., Rajwich, G., Kleiter, I., … Lindena, G.

Mobile Palliative Care Consultation Service (PCCS): Overview of Hospice and Palliative Care Evaluation (HOPE) Data on In-Patients With End-Stage Cancer, Multiple Sclerosis, and Noncancer, Nonneurological Disease From 4 PCCS Centers in Germany in 2013.

Palliative Care: Research and Treatment 2018; 11: 1178224218785139

DOI: 10.1177/1178224218785139  

Gaissmaier W, Giese H, Galesic M, Garcia-Retamero R, Kasper J, Kleiter I, Meuth S, Kopke

S, Heesen C.  

Numeracy of multiple sclerosis patients: A comparison of patients from the

PERCEPT study to a German probabilistic sample.  

Patient Eduction and Counseling 2018 Jan;101(1):74-78, DOI: 10.1016/j.pec.2017.07.018

Grüter, T., Ayzenberg, I., Gahlen, A., Kneiphof, J., Gold, R., & Kleiter, I.  

Flaccid paralysis in neuromyelitis optica: An atypical presentation with possible involvement of the peripheral nervous system.

Multiple Sclerosis and Related Disorders 2018; 25:83–86, DOI: 10.1016/j.msard.2018.07.032  

Grüter Thomas, Metz Imke, Gahlen Anna, Kneiphof Janina, Stork Lidia, Brück Wolfgang, Gold Ralf, Kleiter Ingo.

Mitoxantrone treatment in a patient with multiple sclerosis and pattern III lesions.

Clinical and Experimental Neuroimmunology 2018 Aug; 9(3):169-172

DOI: 10.1111/cen3.12466

Henze, T., Feneberg, W., Flachenecker, P., Seidel, D., Albrecht, H., Starck, M., Meuth, S. G.  

Neues zur symptomatischen MS-Therapie: Teil 3–Blasenfunktionsstörungen.  

Der Nervenarzt 2018 February; 89(2):184-192, DOI: 10.1007/s00115-017-0440-x  

Henze, T., Feneberg, W., Flachenecker, P., Seidel, D., Albrecht, H., Starck, M., Meuth, S. G.

Neues zur symptomatischen MS-Therapie: Teil 4–Störungen der Sexualfunktion und der Augenbewegungen.  

Der Nervenarzt 2018 February; 89(2):193-197, DOI: 10.1007/s00115-017-0441-9  

Henze, T., Feneberg, W., Flachenecker, P., Seidel, D., Albrecht, H., Starck, M., Meuth, S. G.  

Neues zur symptomatischen MS-Therapie: Teil 5–Fatigue.  

Der Nervenarzt April 2018; 89(4):446–452, DOI: 10.1007/s00115-017-0442-8  

Henze, T., Feneberg, W., Flachenecker, P., Seidel, D., Albrecht, H., Starck, M., Meuth, S. G.  

Neues zur symptomatischen MS-Therapie: Teil 6 – kognitive Störungen und Rehabilitation.

Der Nervenarzt April 2018; 89(4):453–459, DOI: 10.1007/s00115-017-0443-7

Hoffmann, Frank, Andrea Kraft, Franz Heigl, Erich Mauch, Jürgen Koehler, Lutz Harms, Tania Kümpfel, et al.  

Tryptophan Immunoadsorption during Pregnancy and Breastfeeding in Patients with Acute Relapse of Multiple Sclerosis and Neuromyelitis Optica.  

Therapeutic Advances in Neurological Disorders 2018 Jan-Dec; 11: 1756286418774973

DOI: 10.1177/1756286418774973  

Huhn, K., Bayas, A., Doerck, S., Frank, B., Gerbershagen, K., Hellwig, K., Kallmann B., Kleinschnitz C., Kleiter I., Lee D.-H., Limmroth V., Mäurer M., Meuth  S., Rieckmann P., Ruck T., Gold R., Linker, R. A.

Alemtuzumab as rescue therapy in a cohort of 50 relapsing–remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.  

Journal of Neurology 2018; 265(7):1521–1527, DOI: 10.1007/s00415-018-8871-2  

Jarius, S., F. Paul, O. Aktas, N. Asgari, R. C. Dale, J. de Seze, D. Franciotta, K. Fujihara, A. Jacob, H.J. Kim, I. Kleiter, T. Kümpfel, M. Levy, J. Palace, K. Ruprecht, A. Saiz, C. Trebst, B.G. Weinshenker, B. Wildemann.

MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antikörpertestung.

Der Nervenarzt, Dezember 2018; 89(12):1388-1399, DOI: 10.1007/s00115-018-0607-0

Jarius S, Ruprecht K, Stellmann J, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M,

Abdelhak A, Gruter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F,

Wildemann B.  

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a

multicenter study of 200 patients and review of the literature.  

Journal of Neuroinflammation 2018 Mar 19;15(1):88. DOI: 10.1186/s12974-018-1108-6

Kleiter, Ingo, Anna Gahlen, Nadja Borisow, Katrin Fischer, Klaus-Dieter Wernecke, Kerstin Hellwig, Florence Pache, et al.  

Apheresis Therapies for NMOSD Attacks.

Neurology - Neuroimmunology & Neuroinflammation 2018 Nov 1; 5(6):504

DOI: 10.1212/NXI.0000000000000504

Kleiter I.

Neue Therapieoptionen für progrediente MS.

Ärztliche Praxis Neurologie Psychiatrie 2018 März-April; (2):26,27-28

Pöllmann, W., Meier, M., Feneberg, W., Ganslmeier, J., & Kleiter, I.  

Thyreotoxikose bei langjähriger Multipler Sklerose?–Fallstricke der MS-Therapie mit Biotin.  

Aktuelle Neurologie 2018 Aug; 45(6):480-484, DOI: 10.1055/a-0575-9909  

Rahn A, Kopke S, Backhus I, Kasper J, Anger K, Untied B, Alegiani A, Kleiter I, Muhlhauser

I, Heesen C.  

Nurse-led immunotreatment DEcision Coaching In people with Multiple

Sclerosis (DECIMS) - feasibility testing, pilot randomised controlled trial and mixed methods

process evaluation.  

International Journal of Nursing Studies 2018 Feb;78: 26-36, DOI: 10.1016/j.ijnurstu.2017.08.011

Rommer, Paulus S, Nicolaus König, Annett Sühnel, Uwe K Zettl.  

Coping behavior in multiple sclerosis—complementary and alternative medicine: A cross-sectional study.

CNS Neuroscience & Therapeutics 2018 Sep; 24(9): 784-789, DOI: 10.1111/cns.12857  

Schelenz, D., Kleiter, I., et al.  

Frühzeitiges Auftreten eines Fingolimod-assoziierten Makulaödems.  

Der Ophthalmologe 2018 May 01; 115(5):424-428, DOI: 10.1007/s00347-017-0526-7  

Schmidt S, Koehler J, Winterstein C, Schicklmaier P, Kallmann B.  

An epidemiological study on the course of disease and therapeutic considerations in relapsing–remitting multiple sclerosis patients receiving injectable first-line disease-modifying therapies in Germany (EPIDEM).  

Therapeutic Advances in Neurological Disorders 2018 Jan-Dec; 11: 1756285617749802

doi:10.1177/1756285617749802

Thone J, Lichtenberg S, Stahl A, Pache F, Kleiter I, Ruprecht K, Gold R, Hellwig H.  

Ovarian reserve in women with neuromyelitis optica spectrum disorder.

Frontiers in Neurology 2018, 9:446, DOI: 10.3389/fneur.2018.00446  

Wilmes A, Reinehr S, Kuehn S, Pedreiturria X, Petrikowski L, Faissner S, Ayzenberg I, Stute

G, Gold R, Dick B, Kleiter I, Joachim S.

Laquinimod protects optic nerve and retina in an experimental autoimmune encephalomyelitis model.  

Journal of Neuroinflammation 2018, 15:183, DOI: 10.1186/s12974-018-1208-3  

BEITRÄGE IN BÜCHERN

Trebst, C., Ayzenberg, I., & Kleiter, I. (2018). Neuromyelitis Optica Spectrum Disorders.  

In Minagar, A. (ed.), Neuroinflammation (pp. 313–335). Elsevier, 2. Ed., 2018.

Henze, T., Feneberg, W., Flachenecker, P., Seidel, D., Albrecht, H., Starck, M., Meuth, S. G. Neues zur symptomatischen MS‑Therapie: Teil 1 - Einleitung und methodisches Vorgehen, Ataxie und Tremor. Der Nervenarzt 2017 December; 88(12):1421-1427.  

Henze, T., Feneberg, W., Flachenecker, P., Seidel, D., Albrecht, H., Starck, M., Meuth, S. G. Neues zur symptomatischen MS‑Therapie: Teil 2 - Gangstörung und Spastik. Der Nervenarzt 2017 December; 88(12):1428-1434. 

Henze, T., Feneberg, W., Flachenecker, P., Seidel, D., Albrecht, H., Starck, M., Meuth, S. G. Neues zur symptomatischen MS-Therapie: Teil 3 - Blasenfunktionsstörungen. Der Nervenarzt 2017 Epub ahead of print. 

Henze, T., Feneberg, W., Flachenecker, P., Seidel, D., Albrecht, H., Starck, M., Meuth, S. G. Neues zur symptomatischen MS-Therapie: Teil 4 - Störungen der Sexualfunktion und der Augenbewegungen. Der Nervenarzt 2017 Epub ahead of print. 

Henze, T., Feneberg, W., Flachenecker, P., Seidel, D., Albrecht, H., Starck, M., Meuth, S. G. Neues zur symptomatischen MS-Therapie: Teil 5 - Fatigue. Der Nervenarzt 2017 Epub ahead of print. 

Henze, T., Feneberg, W., Flachenecker, P., Seidel, D., Albrecht, H., Starck, M., Meuth, S. G. Neues zur symptomatischen MS-Therapie: Teil 6 - kognitive Störungen und Rehabilitation. Der Nervenarzt 2017 Epub ahead of print.

Aktas O, Kleiter I, Kümpfel T, Trebst C. Praktische Aspekte der Diagnostik und Therapie der Neuromyelitis optica-Spektrum-Erkrankungen (NMOSD). In: Qualitätshandbuch MS/NMOSD. 2. überarbeitete und erweiterte Auflage, Juli 2017. Herausgeber:  Krankheitsbezogenes Kompetenznetzwerk Multiple Sklerose e.V. (KKNMS).

Schelenz, D., Kleiter, I., Schöllhammer, J., Rehrmann, J., Elling, M., Dick, H.B., Kakkassery, V. Frühzeitiges Auftreten eines Fingolimod-assoziierten Makulaödems. Der Ophthalmologe 2017 Epub ahead of print. 

Kleiter, I., Lang, M., Jeske, J., Norenberg, C., Stollfuß, B., & Schürks, M. Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study. BMC Neurology 2017 September; 17(1), 174. 

Rommer, P.S., Sühnel, A., König, N., Zettl, U-K. Coping with multiple sclerosis - the role of social support. Acta Neurologica Scandinavica 2017 July; 136(1): 11-16.  

Pöllmann, W., Feneberg, W., Koehler, J. Restless Leg Syndrome (RLS) in Multiple Sclerosis: Occurrence and frequent manifestation with neuropathic pain and phasic spasticity (P3.367). Neurology 2017 April; 88(16 Supplement).